跳至主要内容
临床试验/NCT07303452
NCT07303452招募中不适用

A Multi-center Proof-of-concept Study to Assess the Safety and Effectiveness of the Restera™ Serene™ System When Stimulating the Hypoglossal Nerve Alone or the Hypoglossal Nerve Plus the Ansa Cervicalis Nerve for the Treatment of Obstructive Sleep Apnoea in Adult Participants.

Restera, Inc.1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年12月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20
试验地点
1
主要终点
Safety of the Restera Serene System

研究概览

简要总结

The purpose of this multi-center proof-of-concept safety and efficacy study is to collect chronic sleep-related data following percutaneous placement of electrode arrays near the hypoglossal nerve and the ansa cervicalis in adults with obstructive sleep apnea.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Body Mass Index (BMI) ≤ 32 kg/m2
  • AHI between 15-65 events/hour
  • Participants who have either not tolerated, have failed or refused positive airway pressure (PAP)

排除标准

  • Pregnancy or breast-feeding
  • Significant upper airway anatomic abnormalities
  • Significant positionally-dependent OSA
  • Participants taking medications that may alter body weight

结局指标

主要结局

Safety of the Restera Serene System

时间窗: 6 months

Incidence of device and/or procedure-related serious adverse events

Effectiveness of the Restera Serene System

时间窗: 6 months

Change from baseline in the Apnea-Hypopnea Index

次要结局

  • Long-term Safety of the Restera Serene System(36 months)
  • Long-term Effectiveness of the Restera Serene System(36 months)

研究者

发起方
Restera, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验